VMVladimir Vladimirovich Malashchenko

Vladimir Vladimirovich Malashchenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vladimir Vladimirovich Malashchenko has a total of 125 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Role of MicroRNAs in Mitochondrial Homeostasis and their Involvement in the Pathogenesis of Obesity and Metabolic Syndrome: A Focus on MicroRNAs

    by Natalia Todosenko, Kristina Yurova, Maria Vulf, Olga Khaziakhmatova, Vladimir Malashchenko, Igor Khlusov, Alexandra Komar, Ivan Kozlov, Larisa Litvinova

    The maintenance of the functional potential of mitochondria is directly related to epigenetic factors, microRNAs (miRs), and mitomicroRNAs (mitomiRs). An important role in the development of metabolic syndrome (MetS)/obesity is attributed to miRs, which have pro-inflammatory or anti-inflammatory potential and can penetrate the mitochondrial matrix. Deciphering the mechanisms responsible for the transport of miRs into the mitochondria would, we believe, allow us to use the knowledge obtained to build designs for the transport of drugs/mitomiRs into cells/mitochondria with low toxicity. A thorough understanding of the polyfunctionality/versatility of individual mitomiRs in specific cells (cell cultures, tissues: adipocytes, brain cells) will allow targeting cellular metabolism to comprehensively block the central link in disease pathogenesis with low potential side effects of this treatment. In this review, we have attempted to identify the key miRs/mitomiRs associated with MetS that affect mitochondrial function. In our opinion, further research should focus specifically on the miR/mitomiRs described here and further investigate their potential in the development of MetS and its components.


  • Open Access

    The Role of (Nuclear) Lipid Droplets in the Pathogenesis of Metabolic Syndrome

    by Natalia Todosenko, Kristina Yurova, Olga Khaziakhmatova, Maria Vulf, Vladimir Malashchenko, Aleksandra Komar, Ivan Kozlov, Igor Khlusov, Larisa Litvinova

    Metabolic syndrome (MetS) is a widespread multi-component pathological condition characterized by meta-inflammation and cellular dysfunction. MetS and other metabolic diseases (metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular-kidney-metabolic syndrome (CKMS)) stem from the disorder of energy metabolism and changes in the structure and function of specialized organelles such as lipid droplets, endoplasmic reticula, mitochondria, and nuclei. The discovery of lipid droplets within the nucleus and the investigation of their functions across various cell types in both health and disease provide a foundation for discussing their role in the development and progression of metabolic syndrome. This review examines studies on lipid droplets in the nucleus, focusing on pathways of formation, structure, and function. The importance of (nuclear) lipid droplets in liver and brain is emphasized in the context of inflammation associated with obesity, MetS, and liver disease. This suggests that these structures are promising targets for the development of effective drugs against diseases associated with dysregulation of energy metabolism.


  • Mitochondria and Lipid Droplets: Focus on the Molecular Structure of Contact Sites in the Pathogenesis of Metabolic Syndrome

    by Larisa Sergeevna Litvinova, Maria Aleksandrovna Vulf, Kristina Alekseevna Yurova, Olga Gennadievna Khaziakhmatova, Vladimir Malashchenko, Maria Bograya, Ivan Kozlov, Natalia Todosenko

    Metabolic syndrome (MetS) is a complex of serious pathologies with a high prevalence worldwide. Disruption of mitochondrial biogenesis and its interaction with other cell organelles plays an important role in the development of MetS. Studies have revealed the phenotypic and functional heterogeneity of mitochondria that exist within a single cell and can regulate metabolic signaling pathways, influencing the development of metabolic diseases. Excessive intake of fatty acids leads to changes in fatty acid metabolism that affect the biology of important cell organelles - the lipid droplets, whose specific biology is not fully understood. Perhaps targeted molecular genetic stimulation aimed at regulating the contact between mitochondria and lipids can break the vicious cycle of inflammation in MetS and restore normal cell function, reducing the risk of developing concomitant pathologies. The review describes potential (promising) therapeutic molecular targets associated with mitochondria and lipid droplets, focusing on the proteins involved in their contact and emphasizing their role in the pathogenesis of MetS.


  • Open Access

    Potential targets of heparin during progression and metastasis of malignant neoplasms

    by V. V. Malashchenko, I. A. Khlusov, K. A. Yurova, O. G. Khaziakhmatova, N. M. Todosenko, L. S. Litvinova

    In the modern world, oncological diseases occupy the leading positions in the structure of mortality. An integrated approach to oncotherapy is not only aimed at immediate affection of malignant tumors, but also directed at reducing the risk of tumor recurrence and metastasis, as well as alleviating side effects of chemotherapy and radiotherapy of the disease. In oncologic disorders, blood viscosity increases, thus being associated with hypercoagulation syndrome. To prevent its consequences, the direct and indirect anticoagulants, especially heparin and its derivatives, are actively used. Biological functions and structural features of heparin make it a potential universal platform of a drug development for broad application, including oncology. With the advent of heparin fractionation technology and preparation of low-molecular weight forms and their derivatives, it has become possible to focus not only on anticoagulant activity but also to obtain fractions with targeted pharmacological activity. Usage of the anticoagulants has shown their antitumor activity in some cases, thus providing a basis for a more detailed study of pharmacotherapeutic effects of this group of drugs. Currently, some data suggest various pathways of interaction between heparin and tumor cells. There are multiple common features in development of a primary tumor and formation of secondary distant metastases, which may be attributed to similar molecular cellular mechanisms. The molecules mediating intercellular interactions, both between the tumor cells and between malignant cells and tumor-associated immune cells (e.g., lymphocytes and macrophages) may serve as targets for heparin thus helping the tumor to evade immune surveillance. The cytokines that stimulate tumor angiogenesis represent another important therapeutic target. Heparin derivatives are able to suppress tumor activity and prevent metastatic processes at various stages by inhibiting heparanase, P-/L-selectin, and angiogenesis activity, modulating the CXCL12-CXCR4 chemokine axis, and regulating OAM activity.This brief review addresses the current understanding and application of the potentially antimetastatic properties of heparin and its derivatives in malignant bone tumors since the heparin-based drugs are used as anticoagulants in arthroplasty of large joints and bone defects in patients with osteosarcoma.

  • Features of the Functional Activity of MSC in the Presence of Heparin in Modeling the Mechanisms of Osteointegration Under in Vitro Cultivation

    by I. K. Norkin, K. A. Yurova, O. G. Khaziahmatova, N. M. Todosenko, V. V. Malashchenko, I. A. Khlusov, L. S. Litvinova

  • Morphofunctional reaction of leukocytes and platelets in in vitro contact with a‐C:H:SiOx‐coated Ti–6Al–4V substrate

    by Alexander S. Grenadyorov, Andrey A. Solovyev, Konstantin V. Oskomov, Vjacheslav A. Semenov, Maksim O. Zhulkov, Dmitriy A. Sirota, Alexander M. Chernyavskiy, Nataly A. Karmadonova, Vladimir V. Malashchenko, Larisa S. Litvinova, et al.

    The article deals with the plasma‐assisted chemical vapor deposition of 0.3–1.4 μm thick a‐C:H:SiOx films in a mixture of argon and polyphenylmethylsiloxane vapor onto the Ti–6Al–4V alloy substrate, which is often used as an implant material. The a‐C:H:SiOx film structure is studied by the Fourier‐transform infrared and Raman spectroscopies. The pull‐off adhesion test assesses the adhesive strength of a‐C:H:SiOx films, and the ball‐on‐disk method is employed to measure their wear rate and friction coefficient. According to these studies, a‐C:H:SiOx films are highly adhesive to the Ti–6Al–4V substrate, have low (0.056) friction coefficient and wear rate (9.8 × 10−8 mm3 N−1 m−1) in phosphate‐buffered saline at 40°C. In vitro studies show neither thrombogenicity nor cytotoxicity of the a‐C:H:SiOx film for the human blood mononuclear cells (hBMNCs). The in vitro contact between the hBMNC culture and a‐C:H:SiOx films 0.8–1.4 μm thick deposited onto Ti–6Al–4V substrates reduces a 24‐hour secretion of pro‐inflammatory cytokines and chemokines IL‐8, IL‐17, TNFα, RANTES, and MCP‐1. This reduction is more significant when the film thickness is 1.4 μm and implies its potential anti‐inflammatory effect and possible application in cardiovascular surgery. The dependence is suggested for the concentration of anti‐inflammatory cytokines and chemokines and the a‐C:H:SiOx film thickness, which correlates with the surface wettability and electrostatic potential. The article discusses the possible applications of the anti‐inflammatory effect and low thrombogenicity of a‐C:H:SiOx films in cardiovascular surgery.


  • Open Access

    Study of the Role of Heparin in Regulation of the Morphofunctional Properties of MSC in Vitro

    by I. K. Norkin, K. A. Yurova, O. G. Khaziakhmatova, E. S. Melashchenko, V. V. Malashchenko, E. O. Shunkin, A. N. Baikov, I. A. Khlusov, L. S. Litvinova

    Изучение роли гепарина в регуляции морфофункциональных свойств МСК in vitro


  • Open Access

    Exosome Limitations in the Treatment of Inflammatory Diseases

    by Daria Skuratovskaia, Maria Vulf, Olga Khaziakhmatova, Vladimir Malashchenko, Aleksandra Komar, Egor Shunkin, Natalia Gazatova, Larisa Litvinova

    Background: Despite the great interest and numerous studies, there is currently no unified standard describing the sequential manipulation with cells to obtain exosomes for clinical use.The use of exosomes has become an attractive alternative to cell therapy, since the flexible nature of these biological vesicles allows scientists to manipulate their composition to produce the desired exosomes carrying specific drugs, RNA and proteins. This study aimed to analyse scientific literature on the changes in the functional characteristics of exosomes, depending on the method of manipulation, potentially contributing to the development of negative effects in the treatment of diseases of inflammatory genesis. Results: The choice of isolation method affects the expressed sets of protein markers, nucleic acids and receptors on microparticles. Various surface receptors present on the exosome membrane can be engineered to target lesions. Exosomes from healthy patients help to reduce inflammation, normalize intercellular communication and have anti-fibrotic, antioxidant, and cytoprotective effects. Exosomes can change the microenvironment, but the microenvironment can also change the composition of exosomes. Conclusion: Exosomes obtained from sick patients carry markers characteristic of the corresponding disease. Such exosomes can have pro-inflammatory, pro-fibrotic, cytotoxic, and oncogenic properties, and disrupt cellular cooperation. Until now, questions regarding the dose, reactions to repeated administration, and dosage regimes have not been completely resolved.


  • Open Access

    Zn- or Cu-containing CaP-Based Coatings Formed by Micro-Arc Oxidation on Titanium and Ti-40Nb Alloy: Part II—Wettability and Biological Performance

    by Ekaterina G. Komarova, Yurii P. Sharkeev, Mariya B. Sedelnikova, Oleg Prymak, Matthias Epple, Larisa S. Litvinova, Valeria V. Shupletsova, Vladimir V. Malashchenko, Kristina A. Yurova, Anna N. Dzyuman, et al.

    This work describes the wettability and biological performance of Zn- and Cu-containing CaP-based coatings prepared by micro-arc oxidation on pure titanium (Ti) and novel Ti-40Nb alloy. Good hydrophilic properties of all the coatings were demonstrated by the low contact angles with liquids, not exceeding 45°. An increase in the applied voltage led to an increase of the coating roughness and porosity, thereby reducing the contact angles to 6° with water and to 17° with glycerol. The free surface energy of 75 ± 3 mJ/m2 for all the coatings were determined. Polar component was calculated as the main component of surface energy, caused by the presence of strong polar PO43− and OH− bonds. In vitro studies showed that low Cu and Zn amounts (~0.4 at.%) in the coatings promoted high motility of human adipose-derived multipotent mesenchymal stromal cells (hAMMSC) on the implant/cell interface and subsequent cell ability to differentiate into osteoblasts. In vivo study demonstrated 100% ectopic bone formation only on the surface of the CaP coating on Ti. The Zn- and Cu-containing CaP coatings on both substrates and the CaP coating on the Ti-40Nb alloy slightly decreased the incidence of ectopic osteogenesis down to 67%. The MAO coatings showed antibacterial efficacy against Staphylococcus aureus and can be arranged as follows: Zn-CaP/Ti > Cu-CaP/TiNb, Zn-CaP/TiNb > Cu-CaP/Ti.


  • Open Access

    Calcium Phosphate Coating Prepared by Microarc Oxidation Affects hTERT Expression, Molecular Presentation, and Cytokine Secretion in Tumor-Derived Jurkat T Cells

    by Larisa S. Litvinova, Olga G. Khaziakhmatova, Valeria V. Shupletsova, Kristina A. Yurova, Vladimir V. Malashchenko, Egor O. Shunkin, Pavel A. Ivanov, Ekaterina G. Komarova, Valentina V. Chebodaeva, Ekaterina D. Porokhova, et al.

    Calcium phosphate (CaP) materials are among the best bone graft substitutes, but their use in the repair of damaged bone in tumor patients is still unclear. The human Jurkat T lymphoblast leukemia-derived cell line (Jurkat T cells) was exposed in vitro to a titanium (Ti) substrate (10 × 10 × 1 mm3) with a bilateral rough (average roughness index (Ra) = 2–5 μm) CaP coating applied via the microarc oxidation (MAO) technique, and the morphofunctional response of the cells was studied. Scanning electron microscopy (SEM), X-ray diffraction (XRD), and energy dispersive X-ray spectroscope (EDX) analyses showed voltage-dependent (150–300 V) growth of structural (Ra index, mass, and thickness) and morphological surface and volume elements, a low Ca/PaT ratio (0.3–0.6), and the appearance of crystalline phases of CaHPO4 (monetite) and β-Ca2P2O7 (calcium pyrophosphate). Cell and molecular reactions in 2-day and 14-day cultures differed strongly and correlated with the Ra values. There was significant upregulation of hTERT expression (1.7-fold), IL-17 secretion, the presentation of the activation antigens CD25 (by 2.7%) and CD95 (by 5.15%) on CD4+ cells, and 1.5–2-fold increased cell apoptosis and necrosis after two days of culture. Hyperactivation-dependent death of CD4+ cells triggered by the surface roughness of the CaP coating was proposed. Conversely, a 3.2-fold downregulation in hTERT expression increased the percentages of CD4+ cells and their CD95+ subset (by 15.5% and 22.9%, respectively) and inhibited the secretion of 17 of 27 test cytokines/chemokines without a reduction in Jurkat T cell survival after 14 days of coculture. Thereafter, cell hypoergy and the selection of an hTERT-independent viable CD4+ subset of tumor cells were proposed. The possible role of negative zeta potentials and Ca2+ as effectors of CaP roughness was discussed. The continuous (2–14 days) 1.5–6-fold reductions in the secretion of vascular endothelial growth factor (VEGF) by tumor cells correlated with the Ra values of microarc CaP-coated Ti substrates seems to limit surgical stress-induced metastasis of lymphoid malignancies.